Kronos Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Kronos Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $21.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2025-05-08
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $21.00K.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $57.00K.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $85.00K.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $507.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-03-31 | $21.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $57.00K 10-Q · filed 2025-05-08 |
| 2024-09-30 | $85.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $507.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $426.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $19.00K 10-Q · filed 2024-11-13 |
| 2023-09-30 | $17.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $155.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $44.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $54.00K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $1.37M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $11.97M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $35.33M 10-K · filed 2022-02-24 |
| 2021-09-30 | $67.39M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $88.59M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $121.47M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $132.09M 10-K · filed 2021-03-23 |
| 2020-09-30 | $68.29M 10-Q · filed 2020-11-18 |
| 2019-12-31 | $27.29M 10-Q · filed 2020-11-18 |